Price T Rowe Associates Inc Biolife Solutions Inc Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 15,129 shares of BLFS stock, worth $302,580. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,129
Previous 13,755
9.99%
Holding current value
$302,580
Previous $224,000
25.45%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BLFS
# of Institutions
156Shares Held
44.1MCall Options Held
207KPut Options Held
18.3K-
Casdin Capital, LLC New York, NY8.71MShares$174 Million13.04% of portfolio
-
Black Rock Inc. New York, NY5.46MShares$109 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$57.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.81MShares$36.3 Million0.02% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.73MShares$34.5 Million0.09% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $854M
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...